全文获取类型
收费全文 | 15436篇 |
免费 | 973篇 |
国内免费 | 101篇 |
专业分类
耳鼻咽喉 | 132篇 |
儿科学 | 351篇 |
妇产科学 | 882篇 |
基础医学 | 1920篇 |
口腔科学 | 319篇 |
临床医学 | 1701篇 |
内科学 | 3147篇 |
皮肤病学 | 305篇 |
神经病学 | 1133篇 |
特种医学 | 517篇 |
外科学 | 2078篇 |
综合类 | 538篇 |
一般理论 | 8篇 |
预防医学 | 781篇 |
眼科学 | 427篇 |
药学 | 1079篇 |
中国医学 | 125篇 |
肿瘤学 | 1067篇 |
出版年
2023年 | 57篇 |
2022年 | 44篇 |
2021年 | 309篇 |
2020年 | 157篇 |
2019年 | 312篇 |
2018年 | 420篇 |
2017年 | 257篇 |
2016年 | 285篇 |
2015年 | 468篇 |
2014年 | 547篇 |
2013年 | 767篇 |
2012年 | 1116篇 |
2011年 | 1179篇 |
2010年 | 789篇 |
2009年 | 645篇 |
2008年 | 897篇 |
2007年 | 906篇 |
2006年 | 885篇 |
2005年 | 835篇 |
2004年 | 775篇 |
2003年 | 659篇 |
2002年 | 633篇 |
2001年 | 564篇 |
2000年 | 542篇 |
1999年 | 396篇 |
1998年 | 134篇 |
1997年 | 137篇 |
1996年 | 132篇 |
1995年 | 110篇 |
1994年 | 95篇 |
1993年 | 63篇 |
1992年 | 187篇 |
1991年 | 157篇 |
1990年 | 123篇 |
1989年 | 119篇 |
1988年 | 120篇 |
1987年 | 91篇 |
1986年 | 81篇 |
1985年 | 69篇 |
1984年 | 57篇 |
1983年 | 36篇 |
1982年 | 32篇 |
1981年 | 29篇 |
1980年 | 22篇 |
1979年 | 42篇 |
1978年 | 27篇 |
1977年 | 26篇 |
1976年 | 22篇 |
1975年 | 26篇 |
1973年 | 25篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Lin Shu-I. Liao Feng-Ching Chiou Wei-Ru Lin Po-Lin Kuo Jen-Yuan Tsai Cheng-Ting Lee Ying-Hsiang 《Journal of interventional cardiac electrophysiology》2022,63(2):229-230
Journal of Interventional Cardiac Electrophysiology - 相似文献
2.
Wei-Chih Liao Li-Jen Hsin Hsueh-Yu Li Ming-Shao Tsai Yao-Te Tsai Chung-Chieh Yu Yi-Chan Lee 《Auris, nasus, larynx》2021,48(5):934-941
ObjectiveThe overnight rostral fluid shift from the lower limbs is one of the causes of obstructive sleep apnea (OSA). Compression stockings (CS) prevent lower limb fluid retention and have been reported to decrease nighttime fluid shift. The aim of this study is to evaluate the effect of CS on fluid shift and the severity of OSA.MethodsA systematic literature search was performed in the PubMed, EMBASE and Cochrane Library databases. The data were analyzed using Comprehensive Meta-Analysis software (Version 3; Biostat, Englewood, NJ). Studies evaluating the effect of CS on the overnight fluid shift and OSA severity were included in the analysis.ResultsA total of 4 studies were included in this meta-analysis. The pooled analysis showed that the apnea-hypopnea index (AHI) of the overall study group was significantly lower after using CS (SMD, -1.08; 95% CI, -1.49 to -0.67). Decreases in the AHI were also observed in the normal fluid status (SMD, -1.05; 95% CI, -1.73 to -0.37) and fluid overload status (SMD, -1.17; 95% CI, -1.76 to -0.58) populations. The overall study group had significant decreases in overnight changes in neck circumference (SMD, -1.05; 95% CI, -2.06 to -0.03) and leg fluid volume (SMD, -1.14; 95% CI, -1.88 to -0.41) after using CS. However, no significant differences in overnight changes in neck circumference and leg fluid volume were observed in normal fluid status patients.ConclusionCS may help decrease overnight fluid shift and could be a treatment option for OSA. 相似文献
3.
Tian-Chi Tsai Huan-Ka Chiung Liang-Hsuan Chen Hsien-Ming Wu 《Taiwanese journal of obstetrics & gynecology》2021,60(3):567-569
ObjectiveAssisted oocyte activation combined with ICSI (ICSI-AOA) has been reported to improve fertilization outcomes of couples with oocyte activation deficiency (OAD). Although there's no sufficient evidence to support ICSI-AOA as routine use, it might be beneficial for POSEIDON group 3 patients with suspected oocyte-related OAD.Case reportA 29-year-old female presented with a history of primary infertility for two years. She was classified as a POSEIDON group 3 patient and had a total fertilization failure history. With the help of ICSI-AOA, six oocytes were successfully fertilized. Pregnancy was later confirmed after embryo transfer. A living infant was born after 34 weeks of pregnancy.ConclusionOAD should be taken into consideration for POSEIDON group 3 patients since low Antimüllerian hormone is associated decreased quality. Further research needs to be done to understand the mechanism underlying oocyte-related OAD and the potential role of ICSI-AOA in young patients with suboptimal ovarian response. 相似文献
4.
Her-Shyong Shiah Nai-Jung Chiang Chia-Chi Lin Chia-Jui Yen Hui-Jen Tsai Shang-Yin Wu Wu-Chou Su Kwang-Yu Chang Ching-Chiung Wang Jang-Yang Chang Li-Tzong Chen 《The oncologist》2021,26(4):e567-e579
Lessons Learned
- SCB01A is a novel microtubule inhibitor with vascular disrupting activity.
- This first‐in‐human study demonstrated SCB01A safety, pharmacokinetics, and preliminary antitumor activity.
- SCB01A is safe and well tolerated in patients with advanced solid malignancies with manageable neurotoxicity.
5.
6.
7.
8.
Tien‐Yao Tsai Iat‐Lon Leong Ka‐Shun Cheng Lian‐Ru Shiao Tzu‐Hui Su Kar‐Lok Wong Paul Chan Yuk‐Man Leung 《Fundamental & clinical pharmacology》2019,33(1):52-62
A pathological feature in atherosclerosis is the dysfunction and death of vascular endothelial cells (EC). Oxidized low‐density lipoprotein (LDL), known to accumulate in the atherosclerotic arterial walls, impairs endothelium‐dependent relaxation and causes EC apoptosis. A major bioactive ingredient of the oxidized LDL is lysophosphatidylcholine (LPC), which at higher concentrations causes apoptosis and necrosis in various EC. There is hitherto no report on LPC‐induced cytotoxicity in brain EC. In this work, we found that LPC caused cytosolic Ca2+ overload, mitochondrial membrane potential decrease, p38 activation, caspase 3 activation and eventually apoptotic death in mouse cerebral bEND.3 EC. In contrast to reported reactive oxygen species (ROS) generation by LPC in other EC, LPC did not trigger ROS formation in bEND.3 cells. Pharmacological inhibition of p38 alleviated LPC‐inflicted cell death. We examined whether heparin could be cytoprotective: although it could not suppress LPC‐triggered Ca2+ signal, p38 activation and mitochondrial membrane potential drop, it did suppress LPC‐induced caspase 3 activation and alleviate LPC‐inflicted cytotoxicity. Our data suggest LPC apoptotic death mechanisms in bEND.3 might involve mitochondrial membrane potential decrease and p38 activation. Heparin is protective against LPC cytotoxicity and might intervene steps between mitochondrial membrane potential drop/p38 activation and caspase 3 activation. 相似文献
9.
10.
Merkel cell carcinoma (MCC) is a rare neuroendocrine carcinoma of the skin, for which the exact mechanisms of carcinogenesis remain unknown. Therapeutic options for this highly aggressive malignancy have historically been limited in both their initial response and response durability. Recent improvements in our understanding of MCC tumor biology have expanded therapeutic options for these patients, namely through the use of immunotherapies such as immune checkpoint inhibitors. Further elucidation of the tumor mutational landscape has identified molecular targets for therapies, which have demonstrated success in other cancer types. In this review, we discuss both current and investigational immune and molecular targets of therapy for MCC. 相似文献